Catalytic antibody 14B9 (14B9)

Catalytic antibody 14B9 is a monoclonal antibody, also known as an abzyme, that possesses enzymatic activity. It was specifically engineered to catalyze the 6-endo-tet cyclization of trans-epoxy alcohols into tetrahydropyrans, a chemical transformation that is typically disfavored according to Baldwin's rules for ring closure (Science, 1993). The antibody was generated using a transition-state analog (hapten) that mimics the geometry and electronic properties of the reaction's transition state, thereby lowering the activation energy (Biochemistry, 1999). 14B9 achieves high regioselectivity and rate enhancement through a mechanism involving transition state stabilization and general acid-base catalysis, often attributed to a conserved catalytic dyad of aspartate and histidine residues (ACS Publications, 1999). While primarily utilized as a model system in synthetic organic chemistry and to study the principles of antibody-mediated catalysis, 14B9 and similar abzymes represent a proof-of-concept for the development of highly specific artificial enzymes for therapeutic applications, such as prodrug activation or the neutralization of toxins (NIH, 2010). Such antibodies combine the high specificity of the immune system with the catalytic power of enzymes, offering a unique platform for designing catalysts for reactions with no known natural enzyme counterparts (Annual Review of Immunology, 1990).

Other names

Abzyme 14B9Monoclonal antibody 14B9Antibody 14B9

Catalytic antibody 14B9 functions as an artificial enzyme that facilitates the 6-endo-tet cyclization of trans-epoxy alcohols by stabilizing the reaction's transition state and providing general acid-base catalysis, likely mediated by a conserved Asp-His catalytic dyad (Biochemistry, 1999).